2025 International Congress Archives

Identification of Cerebrotendinous Xanthomatosis in Patients with Neurodegenerative Disorders from the Cincinnati Cohort Biomarker Program

L. Marsili, M. Kauffman, K. Duque, J. Abanto, R. Dutta, T. Pramparo, J. Terner-Rosenthal, A. Espay (Cincinnati, USA)
Identification of Distinctive Iron Deposition Pattern in Subcortical Nuclei of Parkinson’s Disease using Radiomics: A 7T Susceptibility-Weighted Imaging Study

T. Feng, DN. Su, SD. Ding, ZJ. Zhang, Z. Zhang, J. Jing (Beijing, China)
Identification of Genetic Variants in Progressive Supranuclear Palsy in China

Y. Kang, W. Luo (Hangzhou, China)
Identification of Metabolomic & Proteomic Panels for Parkinson’s Disease progression Diagnosis

A. Galal, A. Moustafa, M. Salama (Cairo, Egypt)
Identification of Rigidity in Parkinson’s Disease Using Wearable Technology

P. Sharma, C. Sotirakis, J. Huxley, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)
Identifying Cut-off Values, Effects of AD Co-pathology, Sex Differences, and Temporal Changes of 123I-FP-CIT SPECT in Autopsy-proven LBD

T. Miyagawa, S. Przybelski, C. Cynthia, HK. Minmin, L. Forsberg, J. Fields, S. Mccarter, T. Ferman, V. Ramanan, J. Graff-Radford, D. Jones, R. Savica, D. Knopman, R. Petersen, R. Reichard, A. Nguyen, D. Dickson, M. Murray, G. Day, N. Graff-Radford, C. Lachner, E. St Louis, M. Jain, K. Kantarci, V. Lowe, B. Boeve (ROCHESTER, USA)
Identifying Differential DNA Methylation Pathways in Parkinson’s Disease and REM Sleep Behavior Disorder

Z. Wu, C. Song, J. Ruiz Tejeda, R. Rajmohan, R. Malhas, M. Mapstone, W. Li, N. Phielipp (Irvine, USA)
Identifying subjects at high risk for prodromal Parkinson’s Disease using dopamine transporter imaging deficit in a step-wise recruitment strategy: Data of Healthy Brain Ageing (HeBA)

S. Schade, C. Corinne, S. Ghosh, A. Garrido, E. Lang, P. Mahlknecht, C. Pauly, D. Pilco, R. Rautenkranz, K. Rege, S. Scaglione, S. Schnell, T. Wicke, V. Satagopam, M. Marti, E. Tolosa, W. Poewe, R. Krüger, C. Trenkwalder, B. Mollenhauer (Kassel, Germany)
Identifying the Prognostic Outcomes of Parkinson’s Patients with Impaired Swallow.

J. Acharya, J. Dols, A. Lingeswaran, A. Aranda-Martinez, A. Manzoor, K. Yeong, C. Chikusu, P. Enwere, R. Lisk, K. Soliman, R. Williams, E. Wilkinson (Chertsey, United Kingdom)
Imbalance and falls in individuals with Hereditary Spastic Paraplegia

G. Dos Santos, M. Severiano, A. Ferraz, C. de Araújo, H. Teive, B. Zeigelboim (Curitiba, Brazil)
Immediate Impact of Whole-Body Vibration on Backward Walking in Individuals with Parkinson disease

A. Boddy, K. Barta, M. Flores, K. Sawyer, L. Perry, A. Campbell (Waco, USA)
Immune cell changes in early Dementia with Lewy Bodies

T. Yacoubian, H. Qin, A. Amara, N. Stover, L. Ruffrage, M. Dean, Y. Zhang, R. Kennedy, D. Geldmacher, A. Gerstenecker, D. Standaert, E. Benveniste (AURORA, USA)
Impact 360 Study for Parkinson’s Disease – a controlled phase II feasibility and safety study of a combined exercise, diet and mindfulness intervention

J. Kelly, M. Powell, R. Cloke, J. Yu, S. Stelling, T. Watson, A. Hashimoto, A. Kuan, M. Sacheli, Y. Wang, D. Darabi, S. Appel-Cresswell (Vancouver, Canada)
Impact of Age of Symptom Onset in Essential Tremor on Cognition in Elderly Individuals

C. Sangali, G. Pereira, A. Detogni, N. Bruscato, A. Schuh, C. Rieder (Porto Alegre, Brazil)
Impact of Allogeneic Mesenchymal Stem Cells in Motor and Non-Motor Symptoms of Parkinson’s Disease: A Phase 2 Randomized Trial

M. Schiess, J. Martinez-Lemus, T. Thomas, E. Tharp, C. Onuigbo, J. Suescun, T. Ellmore, T. Le, E. Rodarte-Rascon, R. Ritter Iii, C. Green (Houston, USA)
Impact of Aquaporin-4 polymorphisms on Glymphatic Function and Motor Symptoms in Parkinson’s Disease

J. Qin, M. Zhang (Hangzhou, China)
Impact of Cognition on Social Engagement in Community-based Older Adults with Parkinsonism

M. Roy, Md, D. Gonzalez, Phd, M. Tosin, Phd, C. Goetz, Md, R. Wilson, Phd (Chicago, USA)
Impact of Constipation on Motor and Non-Motor Symptoms in G2019s Lrrk2 Parkinson’s Disease A Retrospective Study

A. Agrebaoui, R. Zouari, A. Mousli, R. Amouri, A. Rachdi, F. Nabli, Z. Saied, S. Ben Sassi (Tunis, Tunisia)
Impact of Gastrointestinal Dysfunction Symptoms on Psychomotor Recovery Following 8-Week Aerobic Interval Training in Parkinson’s Disease – Preliminary Results

K. Lorek, K. Markowska, A. Bereza, E. Koziorowska, S. Budrewicz, P. Nowakowski, S. Chomiak (Wroclaw, Poland)
Impact of Genetically Defined Ancestry on Progression of Idiopathic Parkinson’s Disease.

J. Frost, S. Gray-Rodriguez, L. Wu, M. Lawton, Y. Ben-Shlomo, M. Hu, D. Grosset, R. Real, H. Morris (London, United Kingdom)
Impact of Innovative Physiotherapy Interventions on Motor Function and Quality of Life in Patients with Parkinson’s Disease and Movement Disorders

E. Nakanwagi, G. Wangolo (KAMPALA, Uganda)
Impact of Insurance and Risk Factors on DBS Outcomes

K. Stefanescu, K. Hu, X. Lei, S. Cen, B. Lee, D. Lee, X. Mason (Los Angeles, USA)
Impact of IPX203 (ER CD-LD) on nighttime sleep in patients with Parkinson’s disease experiencing motor fluctuations: A post hoc analysis of the RISE-PD trial

R. Hauser, A. Espay, O. Vaou, J. Aldred, S. Allard, G. Banisadr, S. Fisher (Tampa, USA)
Impact of manganese exposure on neurobehavioral disorders in rats: Insights into oxidative stress pathways and Parkinsonian syndrome pathophysiology

H. Harifi, H. Hami, L. Bikjdaouene (Kenitra, Morocco)
Impact of ND0612 on Levodopa-Induced Dyskinesia in Parkinson’s Disease: Post hoc Analyses From a Randomized, Active-Controlled Study

A. Ellenbogen, R. Pahwa, J. Hernández-Vara, N. Lopes, J. Pereira, A. Espay (Farmington Hills, USA)
Impact of Over-the-counter Cannabidiol Products on Cognition During the Course of Parkinson’s Disease

A. López Lobato, D. Náfate Wences, A. Hernández Medrano, A. Cervantes Arriaga, M. Rodriguez Violante (Mexico, Mexico)
Impact of parkinson’s disease on work disability: a cross-sectional study

S. Secades, C. Martin (Madrid, Spain)
Impact of Patient-Specific Structural Connectivity of STN-DBS on Balance and Mobility – Pilot study

š. Janovič, S. Holly, M. Chmelík, D. Juskanič, L. Pátrovič, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)
Impact of rare lysosomal gene variants on Parkinson’s disease

K. Senkevich, S. Parlar, C. Chantereault, L. Liu, E. Yu, U. Rudakou, J. Ruskey, J. Ahmad, F. Asayesh, D. Spiegelman, C. Waters, O. Monchi, Y. Dauvilliers, N. Dupré, L. Greenbaum, S. Hassin-Baer, I. Miliukhina, A. Timofeeva, A. Emelyanov, S. Pchelina, R. Alcalay, Z. Gan-Or (Montreal, Canada)
Impact of Skin Biopsy Detection of Phosphorylated Alpha-Synuclein and its Distribution Patterns on the Diagnosis of Synucleinopathies

M. Chen, M. Christie (Houston, USA)
Impact of Sleep Disturbance and Early Morning OFF Symptoms on Health-Related Quality of Life in Advanced Parkinson’s Disease

R. Pahwa, I. Malaty, K. Chaudhuri, J. Domingos, M. Heisen, P. Arija, D. Mohan, H. Penton, M. Kuharic, A. Lalla, Z. Baldwin, A. Shewale, C. Yan, M. Boeri (Gainesvile, USA)
Impact of Stigma on Patients Diagnosed with Parkinson’s Disease in Buenos Aires (Argentina) : A Descriptive Study of Psychological, Occupational, and Social Dimensions

JS. Bestoso, R. Sanjinez, J. Ayerbe, C. Stefani, L. Ciancaglini, V. Müller, D J. Bauso (Buenos Aires, Argentina)
Impaired glymphatic clearance independently contributes to poor outcomes in Parkinson’s disease

A. Zarkali, G. Thomas, R. Paterson, N. Hannaway, I. Dobreva, A. Heslegrave, E. Veleva, H. Zetterberg, R. Weil (London, United Kingdom)
Impaired Speech Perception in Noise (SPiN), Hearing Loss, and Cholinergic Denervation in Parkinson’s Disease

S. Roytman, D. Mccaslin, J. Barr, R. Vangel, P. Kanel, N. Bohnen (Ann. Arbor, USA)
Implementation of the Distress Thermometer in a Movement Disorder Clinic

R. Hoe, M. Low, L. Zhou, L. Fu, E. Ng, W. Li, W. Ng, V. Lim, S. Mathivannan, W. Lee, W. Tapin, S. Tan, N. Baharudin, T. Leong, S. Neo, A. Ng (Singapore, Singapore)
Improved Decision-Making for In-Hospital Medication Management in Parkinson’s Disease

R. Diaz-Rincon, M. Liang, A. Ramirez-Zamora, B. Shickel (Gainesvile, USA)
Improved Outcomes for Patients with Autonomic Movement Disorders (AMD) Originally Evaluated for Psychogenic Non-Epileptiform Spells (PNES)

A. Khoo, J. Brik, M. Paul, A. Hohler (Boston, USA)
Improvement in Chorea After Transcarotid Artery Revascularization: A Case Report

A. Bossart, A. Baddour, D. Renner, J. Alshaikh (Salt Lake City, USA)
Improvement of Freezing of Gait with Personalized Rhythmic Auditory Stimulation in Parkinson’s Disease

CH. Tsai, MC. Tsai, BL. Liu, KY. Hung, YK. Sek, HK. Chen, HC. Huang, MK. Lu, JR. Duann (Taichung, Taiwan)
Improvements in Motor and Non-Motor Symptoms of Parkinson’s Disease in Those Treated with Photobiomodulation Plus Exercise: A Sham-Controlled Study

A. Saltmarche, O. Hares, A. Liebert, B. Bicknell, M. Naeser, G. Heller, J. Sykes, K. Togeretz, A. Namini, G. Herkes (Toronto, Canada)
Improving Automatic Speech Recognition for Speakers with Parkinson’s disease

L. Ramig, M. Hasegawa-Johnson, C. Zwilling, H. Hodges, C. Mendes, H. Kim (Urbana, USA)
Improving Diagnosis of Dementia in Parkinson’s Disease: PDCogniCare Australian Program

N. Dissanayaka, D. Pourzinal, E. Mccann, E. Lobo, D. Brooks, D. Sriram, T. Au, L. Mitchell, N. Pachana, S. Naismith, A. Broome, A. Lehn, A. Kelder, J. Liddle, J. King, R. Marsh, S. Robertson, K. Shrubsole, H. Tinson, M. Verreynne, B. Wood, P. Worthy, J. Yang, P. Nestor, M. Chatfield, S. Keramat, E. Tan, T. Piccinini, E. Beattie, G. Byrne, D. Spooner, J. O'Sullivan (Camperdown, Australia)
Improving Guitar Strumming Mechanics in Parkinson’s Disease: A Case Series Using a Forearm Stabilization Device

J. Lenger, S. Matsushita, T. Lesiuk, M. Kerulis, N. Punjabi (Miami, USA)
Improving Motor and Non-motor Symptoms in Parkinson’s Disease: A combined Pharmaceutical and Digital Approach Targeting Parallel Neural Circuits

A. Amedi, N. Saporta, T. Tamir, R. Sivan Hoffmann, M. Catalogna (Herzliya, Israel)
Improving Recruitment of Black and African American Participants in Parkinson’s Genetics Research

N. Louie, C. Kelliher, MN. Dean, D. Hall, EA. Shamim, T. Xie, E. Disbrow, A. Rawls, A. Ameri, S. Chandra, E. Foster, V. Hinson, C. Kilbane, S. Norris, L. Shulman, J. Staisch, LM. Chahine (New York, USA)
Improving Vocal Volume and Quality of Life for People with Parkinson’s Disease (PD) utilizing EMST and SPEAK OUT!® in the In-Patient Multimodal Intensive Neurorehabilitation And Care Setting.

P. Fischetti, J. Yu, M. Mccrossin, L. Rubin (Glen Cove, USA)
Incidence and Associated Factors for Phenoconversion of Parkinson’s Disease in the Chinese Community Older Adults with LRRK2 G2385R and R1628P Variants

J. Liu, T. Mi, Z. Gu, Y. Li, M. Cao, Z. Ren, H. Zhang, M. Chen, J. Chen, L. Ma, X. Xu, C. Han, L. Zhang, J. An, P. Chan (Beijing, China)
Incidence and Determinants of Nodule formation in continuous subcutaneous Foslevodopa/Foscarbidopa Infusion therapy.

S. Bray, D. Tsui, M. Georgiades, X. Chen, D. Galea, H. Morales Briceno, V. Fung (Westmead, Australia)
IncobotulinumtoxinA to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 6-year Interim Results

B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, H. Couckuyt, L. Delameilleure, M. van Zandijcke (Bruges, Belgium)
Incorporating Patient and Care Partner Feedback on the Protocol for a Clinical Trial Assessing Progression in MSA

B. Yang, A. Souza Santana, R. Murphy, C. O’Donnell, M. Jørgensen, L. Kjærsgaard, S. Zanigni (Valby, Denmark)
Increase eye blink rate as a motor fluctuation in levodopa-Induced dyskinesia in parkinson’s disease a forgotten indicator of motor fluctuations a case report

K. Salinas-Barboza, C. Alfaro-Tapia, JM. Altamirano (Mexico, Mexico)
Increased “Off” Time Is Associated With Poorer Clinical and Humanistic Outcomes in Patients With Advancing Parkinson’s Disease: Results From the PROSPECT Observational Study

P. Sanchez Alonso, D. Houghton, F. Ory-Magne, T. Oeda, D. Safarpour, L. Bergmann, P. Kukreja, K. Onuk, S. Wang, C. Yan, D. Standaert (Majadahonda, Spain)
Increased Basal Ganglia And Default-Mode Network Connectivity And Altered Deep Gray Matter Volume In Functional Movement Disorders

E. Sarasso, A. Gardoni, M. Gandolfi, L. Zenere, S. Basaia, E. Canu, E. Sibilla, A. Sandri, IA. Di Vico, M. Fiorio, G. Pedrotti, A. Paolicelli, P. Barone, MT. Pellecchia, R. Erro, S. Cuoco, I. Carotenuto, C. Vinciguerra, A. Botto, M. Amboni, M. Russo, G. Mansueto, FB. Pizzini, M. Barillari, MF. Lauriola, MC. Tozzi, F. Rusciano, C. Geroin, M. Fasoli, A. Marotta, E. Pizzolla, F. Salaorni, I. Lozzi, F. Bombieri, GM. Squintani, S. Mariotto, S. Tamburin, F. Paio, G. de Biasi, G. Piscosquito, M. Tinazzi, M. Filippi, F. Agosta (Milan, Italy)
Increased Health Care Utilization in Children/Adolescents With Tourette Syndrome Treated With Dopamine D2 Receptor Antagonists: An Electronic Medical Records Database Analysis

D. Isaacs, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, K. Tomczak (Nashville, USA)
Increasing Physical Activity in Parkinson’s Disease Via a Remotely Deployed Gamification Intervention

J. Morley, K. Waddell, M. Smith, S. Wood, R. Greysen (Philadelphia, USA)
Independent and Synergistic Effects of Subthalamic Temporal Interference Stimulation on Motor Symptoms in Parkinson’s Disease

A. Li, J. Li, C. Zhang (Shanghai, China)
Individual physiomarkers of levodopa-induced local field potential fluctuations interact with deep brain stimulation in Parkinson’s disease

M. de Neeling, C. Oehrn, B. Keulen, M. Stam, D. Hubers, R. de Bie, P. Schuurman, B. van Wijk, A. Buijink, M. Beudel (Sacramento, USA)
Individuals With a History of Traumatic Brain Injury Have a Higher Prodromal Burden Than Those Without Such a History

A. Mcnamara, S. Hansch-Maher, I. Baetu, L. Collins-Praino (Adelaide, Australia)
Inflammatory profile in LRRK2-associated prodromal and clinical PD:a cross-sectional study

CC. Fan, JY. Liu, JH. Ma, XL. Liu, P. Chan, SY. Liu (Beijing, China)
Influence of age at onset on medication profile in patients with Parkinson’s disease: A prospective study from a tertiary care center in India

VV. Holla, S. Prasad, T. Nagaraj, SGS. Bhat, M. Bhardwaj, DK. Samartha, SS. Nair, P. Mailankody, RR. Mahale, N. Kamble, R. Yadav, PK. Pal (Bengaluru, India)
Influence of Gut Microbiota-Derived TMAO on Disease Severity in Parkinson’s Disease

S. Virameteekul (Bangkok, Thailand)
Initial Evaluation of a Body-worn Bilateral Sensory Electrical Stimulation Cueing System in Reducing Freezing of Gait (FoG) in a Patient in the OFF and ON States

A. Pérez-Soriano, F. Fondevilla, N. Caballol, K. Byrne, G. ólaighin, à. Bayés (Barcelona, Spain)
Initial Experience with a Crossover Study Comparing Automated Connectomic Programming to Standard Clinical Programming for DBS

K. Mann, A. Noecker, A. Frankemolle-Gilbert, A. Klein, A. Dessy, J. Ratliff, M. Maloney, C. Perlmutter, T. Liang, C. Mcintyre, C. Wu (Durham, USA)
Inpatient Multimodal Care Improves Parkinsonian Symptoms Regardless Of Race Or Ethnicity

N. Elayan, L. Rubin, M. Mccrossin, A. Di Rocco, M. Ghilardi (New York, USA)
Inpatient Multimodal Intensive Care in Moderately Advanced Parkinson’s Disease: Role Of Medication Adjustment In Outcome Measures

N. Elayan, L. Rubin, M. Mccrossin, C. Roberts, H. Shakil, A. Di Rocco, M. Ghilardi (Long Island, USA)
Insights into Ancestral Diversity in Parkinson’s Disease Risk: A Comparative Assessment of Polygenic Risk Scores

S. Grant, P. Saffie-Awad, M. Makarious, I. Elsayed, A. Sanyaolu, P. Wild Crea, A. Schumacher Schuh, K. Levine, D. Vitale, M. Koretsky, J. Kim, T. Leal, M. Periñan, S. Dey, A. Noyce, A. Reyes-Palomares, N. Rodriguez-Losada, J. Foo, W. Mohamed, K. Heilbron, L. Norcliffe-Kaufmann, M. Rizig, N. Okubadejo, M. Nalls, C. Blauwendraat, A. Singleton, H. Leonard, I. Mata, S. Bandres-Ciga (Bethesda, USA)
Insights into Genetic Counseling Recall and Clinical Trial Interest in PD GENEration

S. Rao, M. Murray, L. Caboy, R. de Leon, L. Desnoyers, M. Dini, K. Ghosh Galvelis, J. Beck, R. Alcalay (Miami, USA)
Insights into Myoclonus Dystonia from an Indian movement disorder clinic

F. Mustafa, A. Mudda, A. Agarwal, A. Srivastava, D. Garg, A. Garg (New Delhi, India)
Integrated Gestural Motor Behaviors after Insular Infarction: A Case Report

T. Modi, T. Zhang, E. Schipani, M. Bates, N. Mccall-Cray, P. Reuter, E. Scharf (Rochester, USA)
Integrated Management of atypical Parkinsonism: A home-based patient-Centered healthcare model using Telenursing. Baseline data from the Multicentre IMPACT study

R. Cilia, V. Leta, F. Colucci, A. Suppa, F. Valentino, C. Terranova, C. Leuzzi, J. Cordasco, R. Telese, A. Braccia, G. Gaudiano, A. Elia, A. Zampogna, G. Pinola, M. Patera, G. Belluscio, S. Crivellari, E. Antoniazzi, S. Cascino, A. Giaco, A. Masaracchio, C. Moreschi, M. Catotti, R. Eleopra (Messina, Italy)
Integrating Counterclockwise Theory, Mental Imagery, and Art Therapy for Parkinson’s Disease: A Proposed Protocol for Motor and Non-motor Symptom Management

WJ. Hur, HR. Yoo, MS. Park, JW. Seo, JY. Hur (Daejeon, Republic of Korea)
Integrating the Collaborative Care Mental Health Model into Virtual Parkinson’s Disease Care

E. Ferluga, E. Anderson, N. Flanagan, D. Geraldi-Samara, J. Riser, K. Brendle (Chicago, USA)
Integration of Multivariate Time Series Analysis in Assessing Balance Control: A Comprehensive Review of Current Research

M. Ali, D. W. Ismail, H. Elshazly, Y. M.HUSSEINY, S. Elrobeigi, Y. Hamdi, M. Abouelseoud, H. Abdelbar, H. Khabiry, M. M. Elsayed (Giza, Egypt)
Interactions between APOE E4 and idiopathic Parkinson’s disease in age-related hearing loss

M. Kmiecik, M. Mcintyre, B. Nguyen, A. Guan, M. Holmes, S. Aslibekyan (Sunnyvale, USA)
Interferon Therapy in Subacute Sclerosing Panencephalitis: An Underestimated Option?

A. Adhya, J. Parihar, E. Arun, R. Singh, D. Vibha, A. Garg, M. Tripathi (New Delhi, India)
Interlaboratory cross-validation of CSF α-synuclein seeding aggregation assay for parkinsonisms

J. Perez-Montesino, M. Fernandez, R. Ruiz-Garcia, L. Naranjo, C. Painous, A. Camara, A. Perez-Soriano, L. de Mena, Y. Compta (Barcelona, Spain)
International Mentorship in PPMI Clinical Translation (IMPaCT): Engagement Initiatives for Clinical Participants in the United States (US)

L. Lemon, B. Mcmahon, A. Cunningham, H. Hargrave, J. Ewart, N. Alam, N. Whalen, R. Gokarn (New Haven, USA)
Interplay of GBA1 mutations and sex on determining depressive symptoms in Parkinson’s Disease

M. Avenali, P. Mitrotti, CA. Artusi, R. de Micco, G. Giannini, S. Caminiti, C. Ledda, L. Gallo, C. Galandra, A. Mascia, M. Siciliano, F. Pagliuca, L. Sambati, V. Sant'Elia, G. Vornetti, G. Calandra-Buonaura, L. Lopiano, R. Lodi, A. Tessitore, M. Bozzali, EM. Valente (Turin, Italy)
Interpretable Video Analysis for Movement Disorders, A Case Study of Essential Tremor vs. Cortical Myoclonus

R. Martínez-García-Peña, L. Koens, M. Tijssen, G. Azzopardi (Groningen, Netherlands)
Interpretable voice-based detection of Parkinson’s disease using language-independent graph neural networks

S. Patel, C. Antoniades, J. Fitzgerald, O. Bredemeyer (Oxford, United Kingdom)
Interrogating GCase Activity in Human Monocytes Isolated from Parkinson’s Disease Patients Carrying the Asian LRRK2 G2385R and R1628P Variants

TS. Toh, JW. Hor, SY. Lim, LC. Lit, AN. Khairul Anuar, CY. Lew, YW. Tay, JL. Lim, A. Ahmad-Annuar, K. Zeneviciute, D. Alessi, E. Sammler, AH. Tan (Kuala Lumpur, Malaysia)
Intraoperative deep brain stimulation intrinsic lead migration

A. Greven, A. Cheung, B. Zavala, F. Ponce (Phoenix, USA)
Intraoperative Local Field Potentials and Selection of Deep Brain Stimulation Programming Contacts in Patients with Essential Tremor and Parkinson’s Disease

K. Au, W. Vasquez, J. Cheng (Kansas City, USA)
Intrathecal Administration of Human Oral Mucosa Neural Crest Stem Cells in Moderate/Advanced Multiple System Atrophy: Report on Ongoing Phase 1 Study

T. Gurevich, V. Livneh, O. Aizenstein, M. Artzi, A. Ezra, H. Shabtai, H. Rachima, A. Shuster, B. Koren, H. Goltsman, S. Pitaru (Tel Aviv, Israel)
Intravenous L-dopa Administration in PD and DLB Patients with Oral Intake Difficulties: Current Status and Challenges

S. Nishida (Tokai, Japan)
Investigating the cellular consequences of the G2385R LRRK2 variant

P. Lewis, S. Herbst (London, United Kingdom)
Investigating the Global Genetic Spectrum of Monogenic Parkinson’s Disease and Parkinsonism

L. Lange, M. Makarious, M. Avenali, S. Bardien, M. Doquenia, C. Galandra, P. Heutink, J. Junker, Y. Kanana, I. Keller Sarmiento, K. Kumar, H. Leonard, K. Levine, SY. Lim, K. Lohmann, N. Mencacci, M. Nalls, AH. Tan, J. Trinh, EM. Valente, C. Blauwendraat, S. Bandres-Ciga, A. Singleton, ZH. Fang, C. Klein (Bethesda, USA)
Investigating the most robust predictors of tremor’s severity using a computational image processing pipeline for automated feature extraction

R. Guizani, A. Rekik, M. Abid, S. Laataoui, I. Rekik, S. Ben Amor (London, United Kingdom)
Investigating the Neuroprotective Potential of Mushroom Extracts in Parkinson’s Disease In Vitro Models

SEO. Seo, FAZ. Dustov (Tashkent, Uzbekistan)
Investigating the Role of Age and Neurological Status on Adaptive Balance Strategies: A Systematic Review Utilizing Big Data Techniques

N. Ali, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. Mohamed, A. Nagah, M. M. Elsayed (Mansoura, Egypt)
Investigating the role of NLRP3 Inflammasome as Biomarkers and Therapeutic Targets in Parkinson’s Disease Pathogenesis

S. Choudhury, N. Kamble, V. Holla, S. M, P. Pal, R. Yadav, P. Alladi (Bangalore, India)
Investigating the use of Wearable Technologies as a Digital Biomarker for GBA1-Parkinson’s Disease

N. Loefflad, M. Toffoli, E. Menozzi, A. Schapira (London, United Kingdom)
Investigation of Baseline Factors Associated with a Favorable Response to Initial MAO-B Inhibitor Treatment in Parkinson’s Disease

N. Ito, J. Ozawa, K. Kataoka, K. Matsuoka, T. Nakanishi, T. Wada, A. Ishida, M. Kanemoto, T. Oguchi, M. Tsuji, Y. Kiuchi, H. Murakami (Tokyo, Japan)
Investigation of cortex – basal ganglia pathways with cortical stimulation and subthalamic evoked responses in patients with Parkinson’s disease

J-C. Beyer, A. Cavallo, R M. Köhler, J. Vanhoecke, G-H. Schneider, A A. Kühn, W-J. Neumann (Berlin, Germany)
Investigation of the mode of action of a new device for the application of therapeutic vibro-tactile stimulation to the fingertips on brain activity

K. Frey, J. Hügel, L. Lowinski, G. Rennert, C. Castañeda González, I. Klingmann, C. Böhler, C. Hauptmann (Plankstadt, Germany)
iPad App-based Eye Tracking for the Early Detection of Parkinson’s Disease

F. David, J. Koerner, E. Zou, J. Karl, C. Poon, C. Sodini, V. Sze, L. Verhagen-Metman, T. Heldt (Chicago, USA)
IPX203 (ER CD-LD) super-responders: Description of a patient subpopulation reaping extra benefits in dose-response when converting from IR CD-LD

S. Allard, G. Banisadr, S. Fisher, P. Lewitt (Bridgewater, USA)
Is It Better to Sing Together? A Review of Choral Singing for People with Parkinson’s Disease

S. Kolipaka, H. Kong, P. Izbicki (Boca Raton, USA)
Is Urinary Retention a Marker of Possible Prodromal MSA in PAF?

E. Manzoni, I. Cani, G. Carrozzo, G. Giannini, L. Sambati, L. Baldelli, P. Guaraldi, P. Cortelli, G. Calandra-Buonaura (Bologna, Italy)
Isolation of Seeding Competent Material by Means of ThT Extraction

C. Farris, Y. Ma, D. Murphy, S. Rosete-Gonzalez, L. Concha (san diego, USA)
Istradefylline for Freezing of Gait in Parkinson’s Disease: A Systematic Review and Meta-Analysis

A. Fornari Caprara, J. Pitton Rissardo (Camden, USA)